Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 331
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Cefabactin vet 1000 mg V/DCP/16/0018 Le Vet Beheer B.V., Nīderlande QJ01DB01 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Cefalexin monohydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 27-Oct-2021
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-May-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-May-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (22-May-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/16/0018-01 1000 mg 1 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/16/0018-02 1000 mg 2 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/16/0018-03 1000 mg 3 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/16/0018-04 1000 mg 4 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/16/0018-05 1000 mg 5 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/16/0018-06 1000 mg 6 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/16/0018-07 1000 mg 7 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/16/0018-08 1000 mg 8 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/16/0018-09 1000 mg 9 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/16/0018-10 1000 mg 10 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/16/0018-11 1000 mg 25 PVDH/PE/PVH/Al blisteris, 10 tablete -
Eflunex 50 mg/ml V/DCP/24/0064 Industrial Veterinaria, S.A., Spānija QM01AG90 cattle; pigs; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Flunixin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija;Industrial Veterinaria, S.A., Spānija;aniMedica Herstellungs GmbH, Vācija
Date of authorisation/renewal: 19-Sep-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Jun-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Jun-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Jun-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0064-01 1 Stikla flakons, 50 ml -
V/DCP/24/0064-02 1 Stikla flakons, 100 ml -
V/DCP/24/0064-03 1 Stikla flakons, 250 ml -
Syncroprost 0.250 mg/ml V/DCP/22/0016 Ceva Sante Animale', Francija QG02AD90 cattle; pigs; goats; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Cloprostenol sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Vetem S.p.A., Itālija
Date of authorisation/renewal: 26-May-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Jul-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Jul-2025)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (08-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0016-01 1 Stikla flakons, 10 ml -
V/DCP/22/0016-02 1 Stikla flakons, 20 ml -
V/DCP/22/0016-03 10 Stikla flakons, 20 ml -
V/DCP/22/0016-04 1 Stikla flakons, 50 ml -
V/DCP/22/0016-05 1 Stikla flakons, 100 ml -
Selehold 30 mg V/DCP/18/0068 KRKA, d.d., Novo mesto, Slovēnija QP54AA05 dogs 2,6 - 5,0 kg Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Selamectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija
Date of authorisation/renewal: 04-Dec-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Dec-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Dec-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (20-Dec-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0068-01 1 Polipropilēna pipete, 0,25 ml/deva -
V/DCP/18/0068-02 3 Polipropilēna pipete, 0,25 ml/deva -
V/DCP/18/0068-03 6 Polipropilēna pipete, 0,25 ml/deva -
V/DCP/18/0068-04 15 Polipropilēna pipete, 0,25 ml/deva -
Selehold 60 mg V/DCP/18/0069 KRKA, d.d., Novo mesto, Slovēnija QP54AA05 dogs 5,1–10,0 kg Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Selamectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija
Date of authorisation/renewal: 04-Dec-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Dec-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Dec-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (20-Dec-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0069-01 1 Polipropilēna pipete, 0,5 ml/deva -
V/DCP/18/0069-02 3 Polipropilēna pipete, 0,5 ml/deva -
V/DCP/18/0069-03 6 Polipropilēna pipete, 0,5 ml/deva -
V/DCP/18/0069-04 15 Polipropilēna pipete, 0,5 ml/deva -
Selehold 120 mg V/DCP/18/0070 KRKA, d.d., Novo mesto, Slovēnija QP54AA05 dogs 10,1–20,0 kg Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Selamectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija
Date of authorisation/renewal: 04-Dec-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Dec-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Dec-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (20-Dec-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0070-01 1 Polipropilēna pipete, 1 ml/deva -
V/DCP/18/0070-02 3 Polipropilēna pipete, 1 ml/deva -
V/DCP/18/0070-03 6 Polipropilēna pipete, 1 ml/deva -
V/DCP/18/0070-04 15 Polipropilēna pipete, 1 ml/deva -
Selehold 240 mg V/DCP/18/0071 KRKA, d.d., Novo mesto, Slovēnija QP54AA05 dogs 20,1–40,0 kg Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Selamectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija
Date of authorisation/renewal: 04-Dec-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Dec-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Dec-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (20-Dec-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0071-01 1 Polipropilēna pipete, 2 ml/deva -
V/DCP/18/0071-02 3 Polipropilēna pipete, 2 ml/deva -
V/DCP/18/0071-03 6 Polipropilēna pipete, 2 ml/deva -
V/DCP/18/0071-04 15 Polipropilēna pipete, 2 ml/deva -
Selehold 360 mg V/DCP/18/0072 KRKA, d.d., Novo mesto, Slovēnija QP54AA05 dogs 40,1–60,0 kg Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Selamectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija
Date of authorisation/renewal: 04-Dec-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Dec-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Dec-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (20-Dec-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0072-01 1 Polipropilēna pipete, 3 ml/deva -
V/DCP/18/0072-02 3 Polipropilēna pipete, 3 ml/deva -
V/DCP/18/0072-03 6 Polipropilēna pipete, 3 ml/deva -
V/DCP/18/0072-04 15 Polipropilēna pipete, 3 ml/deva -
Metricure 500 mg V/NRP/96/0343 Intervet International B.V., Nīderlande QG51AA05 cattle Vairāk

Medicinal product information

Pharmaceutical form: intrauterine suspension
International name (active substance): Cephapirin benzathine
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International Booxmer, Nīderlande
Date of authorisation/renewal: 15-Oct-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (13-Jun-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (13-Jun-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (13-Jun-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/96/0343-01 500 mg/deva 10 Šļirce, 1 deva -
Nobilis RT+IBmulti+ND+EDS - V/MRP/15/0010 Intervet International B.V., Nīderlande QI01AA18 chickens Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Inactivated infectious bronchitis virus, serotype Massachusetts, strain M41, Inactivated Newcastle disease virus, strain Clone 30, Inactivated Avian Rhinotracheitis virus, strain But 1#8544, Inactivated infectious bronchitis virus, strain 249g, Inactivated Egg Drop syndrome virus ’76, strain BC14
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 02-Jan-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Apr-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Apr-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (25-Apr-2023)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/15/0010-01 1 Flakons, 500 deva -
V/MRP/15/0010-02 1 Flakons, 1000 deva -
BioBos RCC - V/DCP/22/0030 Bioveta, a.s., Čehija QI02AL01 cattle

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Bovine rotavirus, strain TM-91, Inactivated, Bovine coronavirus, strain C-197, Inactivated, Escherichia coli, fimbrial adhesin F5
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 27-Jul-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [DOC] 270722_LI (27-Jul-2022)
Labelling text: [DOC] 270722_M (27-Jul-2022)
Summary of product characteristics: [DOC] 270722_ZA (27-Jul-2022)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0030-01 2 Stikla flakons, 1 deva -
V/DCP/22/0030-02 10 Stikla flakons, 1 deva -
V/DCP/22/0030-03 20 Stikla flakons, 1 deva -
V/DCP/22/0030-04 1 Stikla flakons, 5 deva -
V/DCP/22/0030-05 1 ABPE flakons, 5 deva -
V/DCP/22/0030-06 5 Stikla flakons, 5 deva -
V/DCP/22/0030-07 5 ABPE flakons, 5 deva -
V/DCP/22/0030-08 10 Stikla flakons, 5 deva -
V/DCP/22/0030-09 10 ABPE flakons, 5 deva -
V/DCP/22/0030-10 1 Stikla flakons, 25 deva -
V/DCP/22/0030-11 1 ABPE flakons, 25 deva -
V/DCP/22/0030-12 12 Stikla flakons, 25 deva -
V/DCP/22/0030-13 12 ABPE flakons, 25 deva -
V/DCP/22/0030-14 24 Stikla flakons, 25 deva -
V/DCP/22/0030-15 24 ABPE flakons, 25 deva -
V/DCP/22/0030-16 1 Stikla flakons, 50 deva -
V/DCP/22/0030-17 1 ABPE flakons, 50 deva -
Effinol 2.5 mg/ml V/DCP/14/0057 Laboratorios Calier, S.A., Spānija QP53AX15 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: cutaneous spray, solution
International name (active substance): Fipronil
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Laboratorios Calier, S.A., Spānija
Date of authorisation/renewal: 30-Oct-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (16-Oct-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (16-Oct-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (16-Oct-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0057-01 2,5 mg/ml 1 Polipropilēna pudele, 100 ml -
V/DCP/14/0057-02 2,5 mg/ml 1 Polipropilēna pudele, 250 ml -
V/DCP/14/0057-03 2,5 mg/ml 1 Polipropilēna pudele, 500 ml -
Repose vet 500 mg/ml V/DCP/17/0021 Le Vet Beheer B.V., Nīderlande QN51AA01 cattle; rodents; pigs; sheep; goats; horses; dogs; cats; rabbits; minks Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Pentobarbital Sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Produlab Pharma b.v., Nīderlande
Date of authorisation/renewal: 26-May-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Jan-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Jan-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (10-Jan-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0021-01 500 mg/ml 1 Stikla flakons, 100 ml -
V/DCP/17/0021-02 500 mg/ml 12 Stikla flakons, 100 ml -
V/DCP/17/0021-03 500 mg/ml 1 Stikla flakons, 250 ml -
V/DCP/17/0021-04 500 mg/ml 12 Stikla flakons, 250 ml -
V/DCP/17/0021-05 500 mg/ml 1 Polipropilēna flakons, 100 ml -
V/DCP/17/0021-06 500 mg/ml 12 Polipropilēna flakons, 100 ml -
V/DCP/17/0021-07 500 mg/ml 1 Polipropilēna flakons, 250 ml -
V/DCP/17/0021-08 500 mg/ml 12 Polipropilēna flakons, 250 ml -
Trilotab vet 120 mg V/DCP/23/0042 CP-Pharma Handelsgesellschaft GmbH, Vācija QH02CA01 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Trilostane
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 27-Jul-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jul-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jul-2023)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (29-Nov-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0042-01 3 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/23/0042-02 10 AL/PVC-AL-PA blisteris, 10 tablete -
MAROPITANT Bioveta 10 mg/ml V/DCP/25/0005 Bioveta, a.s., Čehija QA04AD90 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Maropitant citrate monohydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 03-Feb-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Feb-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Feb-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Feb-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0005-01 1 I tipa stikla flakons, 10 ml -
E-Selensol - V/DCP/21/0026 Labiana Life Sciences S.A., Spānija QA12CE99 cattle; pigs; sheep Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): All-Rac-Alpha-Tocopheryl Acetate, Sodium selenite
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Labiana Life Sciences S.A., Spānija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [DOCX] 210421LI (21-Apr-2021)
Labelling text: [DOCX] 210421M (21-Apr-2021)
Summary of product characteristics: [DOCX] 210421ZA (21-Apr-2021)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/21/0026-01 1 Stikla flakons, 50 ml -
V/DCP/21/0026-02 1 Stikla flakons, 100 ml -
Zoletil 50 - V/NRP/07/1710 Virbac S.A., Francija QN01AX99 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for solution for injection
International name (active substance): Tiletamine hydrochloride,Zolazepam hydrochloride
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Virbac S.A., Francija
Date of authorisation/renewal: 15-Jan-2013
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOC] 270323LI (27-Mar-2023)
Labelling text: [DOC] 270323M (27-Mar-2023)
Summary of product characteristics: [DOC] 270323ZA (27-Mar-2023)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/07/1710-01 1 Flakons (šķīdinātājs), 5 ml;Flakons (liofilizāts), 675 mg -
Vitaminthe - V/NRP/00/1232 Virbac S.A., Francija QP52AC57 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: paste for oral use
International name (active substance): Niclosamide, Oxybendazole
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Virbac S.A., Francija
Date of authorisation/renewal: 09-Jul-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 210202023_LI (20-Mar-2023)
Labelling text: [PDF] 310118M (02-Feb-2018)
Summary of product characteristics: [DOCX] 210202023_ZA (20-Mar-2023)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/00/1232-01 1 Polipropilēna šļirce, 5 ml -
V/NRP/00/1232-02 1 Polipropilēna šļirce, 10 ml -
V/NRP/00/1232-03 1 Polipropilēna šļirce, 25 ml -
Milprazon 2,5 mg/25 mg - V/DCP/14/0065 KRKA, d.d., Novo mesto, Slovēnija QP54AB51 small dogs; puppies weighing at least 0.5 kg Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija
Date of authorisation/renewal: 03-Feb-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Mar-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Mar-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (20-Mar-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0065-01 1 Al/OPA/Al/PVH blisteris, 2 tablete -
V/DCP/14/0065-02 1 Al/OPA/Al/PVH blisteris, 4 tablete -
V/DCP/14/0065-03 12 Al/OPA/Al/PVH blisteris, 4 tablete -
Milprazon 12,5 mg/125 mg - V/DCP/14/0066 KRKA, d.d., Novo mesto, Slovēnija QP54AB51 dogs weighing at least 5 kg Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija
Date of authorisation/renewal: 03-Feb-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Mar-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Mar-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (20-Mar-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0066-01 1 Al/OPA/Al/PVH blisteris, 2 tablete -
V/DCP/14/0066-02 1 Al/OPA/Al/PVH blisteris, 4 tablete -
V/DCP/14/0066-03 12 Al/OPA/Al/PVH blisteris, 4 tablete -

3082 records

© Food and veterinary service · 2026 Cookies policy